Smith AL - Search Results

1

Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer.

Lopez-Anaya A, Unadkat JD, Schumann LA, Smith AL. Lopez-Anaya A, et al. Among authors: smith al. J Acquir Immune Defic Syndr (1988). 1990;3(10):959-64. J Acquir Immune Defic Syndr (1988). 1990. PMID: 2398459

2

Effect of age on distribution of zidovudine (azidothymidine) into the cerebrospinal fluid of Macaca nemestrina.

Lopez-Anaya A, Unadkat JD, Calkins DF, Smith AL. Lopez-Anaya A, et al. Among authors: smith al. Pharm Res. 1993 Sep;10(9):1338-40. doi: 10.1023/a:1018977915364. Pharm Res. 1993. PMID: 8234173

3

Pharmacokinetics of zidovudine (azidothymidine). III. Effect of pregnancy.

Lopez-Anaya A, Unadkat JD, Schumann LA, Smith AL. Lopez-Anaya A, et al. Among authors: smith al. J Acquir Immune Defic Syndr (1988). 1991;4(1):64-8. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1984057

4

Pharmacokinetics of zidovudine (azidothymidine). II. Development of metabolic and renal clearance pathways in the neonate.

Lopez-Anaya A, Unadkat JD, Schumann LA, Smith AL. Lopez-Anaya A, et al. Among authors: smith al. J Acquir Immune Defic Syndr (1988). 1990;3(11):1052-8. J Acquir Immune Defic Syndr (1988). 1990. PMID: 2120418

5

Disposition of drugs in cystic fibrosis. VI. In vivo activity of cytochrome P450 isoforms involved in the metabolism of (R)-warfarin (including P450 3A4) is not enhanced in cystic fibrosis.

Wang JP, Unadkat JD, McNamara S, O'Sullivan TA, Smith AL, Trager WF, Ramsey B. Wang JP, et al. Among authors: smith al. Clin Pharmacol Ther. 1994 May;55(5):528-34. doi: 10.1038/clpt.1994.66. Clin Pharmacol Ther. 1994. PMID: 8181197

6

Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin.

Wang JP, Unadkat JD, al-Habet SM, O'Sullivan TA, Williams-Warren J, Smith AL, Ramsey B. Wang JP, et al. Among authors: al habet sm, smith al. Clin Pharmacol Ther. 1993 Sep;54(3):293-302. doi: 10.1038/clpt.1993.150. Clin Pharmacol Ther. 1993. PMID: 8375124

7

Disposition of drugs in cystic fibrosis. V. In vivo CYP2C9 activity as probed by (S)-warfarin is not enhanced in cystic fibrosis.

O'Sullivan TA, Wang JP, Unadkat JD, al-Habet SM, Trager WF, Smith AL, McNamara S, Aitken ML. O'Sullivan TA, et al. Among authors: al habet sm, smith al. Clin Pharmacol Ther. 1993 Sep;54(3):323-8. doi: 10.1038/clpt.1993.154. Clin Pharmacol Ther. 1993. PMID: 8375128

8

Disposition of drugs in cystic fibrosis. VII. Acetylation of sulfamethoxazole in blood cells: in vitro-in vivo correlation and characterization of its kinetics of acetylation in lymphocytes.

Hutabarat RM, Smith AL, Unadkat JD. Hutabarat RM, et al. Among authors: smith al. Clin Pharmacol Ther. 1994 Apr;55(4):427-33. doi: 10.1038/clpt.1994.52. Clin Pharmacol Ther. 1994. PMID: 8162669

9

Disposition of drugs in cystic fibrosis. II. Hepatic blood flow.

O'Sullivan TA, Bauer LA, Horn JR, Zierler BK, Strandness DE Jr, Williams-Warren J, Smith AL, Unadkat JD. O'Sullivan TA, et al. Among authors: smith al. Clin Pharmacol Ther. 1991 Oct;50(4):450-5. doi: 10.1038/clpt.1991.163. Clin Pharmacol Ther. 1991. PMID: 1914381

10

Disposition of drugs in cystic fibrosis. I. Sulfamethoxazole and trimethoprim.

Hutabarat RM, Unadkat JD, Sahajwalla C, McNamara S, Ramsey B, Smith AL. Hutabarat RM, et al. Among authors: smith al. Clin Pharmacol Ther. 1991 Apr;49(4):402-9. doi: 10.1038/clpt.1991.47. Clin Pharmacol Ther. 1991. PMID: 2015729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,368 results

Search Page

Filters